InDevR InDevR Gets FDA 510(k) Clearance for Influenza Assay The in vitro diagnostic is designed to detect whole gene segments for influenza A and B viruses and can characterize viruses as seasonal or nonseasonal. InDevR Receives ISO 13485:2003 Certification The certification comes ahead of the company's planned launch of a microarray-based test for differentiating seasonal and non-seasonal influenza viruses. InDevR, St. Jude Collaborate to Evaluate Influenza Test St. Jude's Richard Webby will assess the performance of InDevR's FluChip-8G test on non-seasonal influenza viruses. New Products: Agilent SurePrint miRNA Arrays; BioNano Irys System; InDevR Flu Titer on Chip Premium Agilent Technologies this week announced updates to its SurePrint miRNA Microarrays to include targets from the latest version of the miRBase public miRNA database. Cepheid Xpert Flu Validated in ER Setting as Firm Targets Rapidly Crowding Flu MDx Market Premium NEW YORK (GenomeWeb) — Researchers at Johns Hopkins University have performed the first validation of the Cepheid Xpert Flu assay in a population of emergency room patients with acute undifferentiated respiratory illness. Sep 23, 2014 InDevr Planning 2016 Launch for FluChip-8G, Aims to Make Test 'Standard of Care' for Flu Dx Premium Sep 15, 2014 InDevr Inks $14.7M BARDA Contract to Develop FluChip Test Apr 29, 2014 Applied Microarrays, InDevR Partner to Offer Custom Array Manufacturing, Instruments, Assays Premium Apr 29, 2014 InDevR, Applied Microarrays Partner to Deliver Custom Array Offering Feb 23, 2012 GE Global Research, InDevR to Develop DARPA-funded POC Dx Nov 29, 2011 New Products: Indevr's AmpliPhox System Premium Mar 11, 2011 InDevR Wins $3M SBIR Award Aug 17, 2010 InDevr Prepares POC AmpliPhox System for Q4 Debut, RUO FluChip to Launch in 2011 Premium May 11, 2010 InDevr, CDC Partner on Flu Chip Development Premium May 11, 2010 InDevR to Develop Influenza Assay with CDC Breaking News Delic Partners With GT Research for Genetic Analysis of Cannabis, Psychedelic Mushrooms Indivumed, Biognosys Expand Partnership to Offer Immunopeptidomics Insights Multiomic Study Identifies Drivers of Severe COVID-19 in Patients Under 50 Without Comorbidities Yourgene H1 2022 Revenues More Than Double Gencove Raises $10M in Series A Financing Blueprint Genetics, BioMarin to Offer Genetic Testing for Skeletal Dysplasia in Europe, Middle East The Scan Should've Been Spotted Sooner Scientists tell the Guardian that SARS-CoV-2 testing issues at a UK lab should have been noticed earlier. For Martian Fuel Researchers have outlined a plan to produce rocket fuel on Mars that uses a combination of sunlight, carbon dioxide, frozen water, cyanobacteria, and engineered E. coli, according to Gizmodo. To Boost Rapid Testing The Washington Post writes that new US programs aim to boost the availability of rapid at-home SARS-CoV-2 tests. PNAS Papers on Strawberry Evolution, Cell Cycle Regulators, False-Positive Triplex Gene Editing In PNAS this week: strawberry pan-genome, cell cycle-related roles for MDM2 and MDMX, and more.